Avience Biomedicals Limited
Avience Biomedicals Limited was a SME-platform initial public offer.
The book was open from 18 June 2026 to 22 June 2026.
The issue was priced at ₹208 a share, from a band of ₹196 to ₹208.
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
The shares listed on 25 June 2026.
This issue has no ISIN on file, so its listed price history cannot be matched.
The exchange’s record for an issue of this vintage carries the price and the dates only — lot size, issue size and the fresh-versus-offer-for-sale split were not published in the feed. The offer documents below are the source for those.
- Registrar
- Skyline Financial Services Private Limited
- Lead manager
- Fintellectual Corporate Advisors Private Limited
- Bidding opens18 Jun 2026
- Bidding closes22 Jun 2026
- Basis of allotmentnot published
Not published in the exchange feeds we ingest — we do not estimate it.
- Listing25 Jun 2026
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
We have not extracted an anchor allotment list for this issue.
- All other pre-issue capitalSEBI ICDR 2018 Reg. 17 — all other pre-issue capital, 6 months from allotment25 Dec 2026whole tranche releases on this date
- Promoters' minimum contributionSEBI ICDR 2018 Reg. 16(1)(a) — promoters' minimum contribution, 18 months from allotment25 Dec 2027whole tranche releases on this date
Computed from the SEBI ICDR 2018 lock-in rules, not disclosed by the issuer or the exchange. The regulation counts from the date of allotment, which no feed we ingest publishes, so these are counted from the listing date and fall at most two to three business days later than the true expiry.
The "Basis for Offer Price" chapter states the earnings the price was set against and the multiples it implies. We have not extracted it for this issue — several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
The peer table is printed in the offer document's "Basis for Offer Price" chapter; we have not extracted it for this issue yet.
| Firm | Issues | Typical listing move | Below issue @30d | @90d | @180d |
|---|---|---|---|---|---|
Fintellectual Corporate Advisors Private Limited 2026 – 2026 | 1 0 measurable | — | — | — | — |
| Firm | Issues | Typical listing move | Below issue @30d | @90d | @180d |
|---|---|---|---|---|---|
Skyline financial services private limited 2021 – 2026 | 79 2 measurable | +12.3% | 1 of 3 | 1 of 3 | 1 of 4 |
A count of what happened to the other issues each firm was named on, computed from exchange closes. Not a rating, not a ranking, and not a view on the firm.
- Prospectus· PDF · exchange archive23 Jun 2026
- Red herring prospectus (RHP)· ZIP · exchange archive12 Jun 2026
- Draft red herring prospectus (DRHP)· ZIP · exchange archive24 Jul 2025
- Draft red herring prospectus (DRHP)· ZIP · exchange archive27 Dec 2024
- Financial ratios advertisement· ZIP · exchange archive
Filed with SEBI and the exchanges by the issuer. These are the source for every figure on this page.
Compiled from NSE and SEBI offer documents and exchange feeds. A description of the issue and of the bids received — not investment advice, and not a view on whether to apply. No grey-market premium, no allotment lookup and no listing-gain estimate is published here.